Free Trial

Diploma (DPLM) Competitors

Diploma logo
GBX 6,725 +40.00 (+0.60%)
As of 05:22 AM Eastern

DPLM vs. IGG, DPH, HWDN, CTY, and GNS

Should you buy Diploma stock or one of its competitors? MarketBeat compares Diploma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Diploma include IG Group (IGG), Dechra Pharmaceuticals (DPH), Howden Joinery Group (HWDN), City of London (CTY), and Genus (GNS). These companies are all part of the "personal services" industry.

How does Diploma compare to IG Group?

Diploma (LON:DPLM) and IG Group (LON:IGG) are both mid-cap personal services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

In the previous week, Diploma and Diploma both had 1 articles in the media. Diploma's average media sentiment score of 0.00 equaled IG Group'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Diploma
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IG Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

IG Group has lower revenue, but higher earnings than Diploma. IG Group is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.52B5.92£115.40M£137.3048.98
IG Group£949.10M5.30£533.35M£105.1014.45

Diploma has a beta of 0.917, suggesting that its share price is 8% less volatile than the broader market. Comparatively, IG Group has a beta of 0.487, suggesting that its share price is 51% less volatile than the broader market.

IG Group has a net margin of 35.26% compared to Diploma's net margin of 8.99%. IG Group's return on equity of 20.91% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma8.99% 14.17% 8.32%
IG Group 35.26%20.91%10.37%

Diploma currently has a consensus target price of GBX 6,251.25, suggesting a potential downside of 7.04%. IG Group has a consensus target price of GBX 1,302, suggesting a potential downside of 14.29%. Given Diploma's higher probable upside, equities research analysts clearly believe Diploma is more favorable than IG Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
IG Group
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Diploma pays an annual dividend of GBX 60.20 per share and has a dividend yield of 0.9%. IG Group pays an annual dividend of GBX 46.50 per share and has a dividend yield of 3.1%. Diploma pays out 43.8% of its earnings in the form of a dividend. IG Group pays out 44.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

68.2% of Diploma shares are held by institutional investors. Comparatively, 74.0% of IG Group shares are held by institutional investors. 1.1% of Diploma shares are held by company insiders. Comparatively, 1.2% of IG Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

IG Group beats Diploma on 9 of the 16 factors compared between the two stocks.

How does Diploma compare to Dechra Pharmaceuticals?

Diploma (LON:DPLM) and Dechra Pharmaceuticals (LON:DPH) are both mid-cap personal services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

Diploma pays an annual dividend of GBX 60.20 per share and has a dividend yield of 0.9%. Dechra Pharmaceuticals pays an annual dividend of GBX 45 per share. Diploma pays out 43.8% of its earnings in the form of a dividend. Dechra Pharmaceuticals pays out -18,000.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

68.2% of Diploma shares are held by institutional investors. Comparatively, 105.5% of Dechra Pharmaceuticals shares are held by institutional investors. 1.1% of Diploma shares are held by company insiders. Comparatively, 9.3% of Dechra Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Diploma has a net margin of 8.99% compared to Dechra Pharmaceuticals' net margin of -3.66%. Diploma's return on equity of 14.17% beat Dechra Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma8.99% 14.17% 8.32%
Dechra Pharmaceuticals -3.66%-3.92%0.75%

Diploma currently has a consensus target price of GBX 6,251.25, suggesting a potential downside of 7.04%. Given Dechra Pharmaceuticals' higher probable upside, analysts clearly believe Dechra Pharmaceuticals is more favorable than Diploma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Dechra Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Diploma has a beta of 0.917, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Dechra Pharmaceuticals has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

Diploma has higher revenue and earnings than Dechra Pharmaceuticals. Dechra Pharmaceuticals is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.52B5.92£115.40M£137.3048.98
Dechra Pharmaceuticals£761.50M0.00-£27.90M-£0.25N/A

In the previous week, Diploma had 1 more articles in the media than Dechra Pharmaceuticals. MarketBeat recorded 1 mentions for Diploma and 0 mentions for Dechra Pharmaceuticals. Diploma's average media sentiment score of 0.00 equaled Dechra Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Diploma Neutral
Dechra Pharmaceuticals Neutral

Summary

Diploma beats Dechra Pharmaceuticals on 12 of the 16 factors compared between the two stocks.

How does Diploma compare to Howden Joinery Group?

Howden Joinery Group (LON:HWDN) and Diploma (LON:DPLM) are both mid-cap personal services companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

67.4% of Howden Joinery Group shares are held by institutional investors. Comparatively, 68.2% of Diploma shares are held by institutional investors. 0.9% of Howden Joinery Group shares are held by company insiders. Comparatively, 1.1% of Diploma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Diploma had 1 more articles in the media than Howden Joinery Group. MarketBeat recorded 1 mentions for Diploma and 0 mentions for Howden Joinery Group. Howden Joinery Group's average media sentiment score of 0.00 equaled Diploma'saverage media sentiment score.

Company Overall Sentiment
Howden Joinery Group Neutral
Diploma Neutral

Howden Joinery Group has higher revenue and earnings than Diploma. Howden Joinery Group is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howden Joinery Group£2.42B1.64£253.42M£49.0015.02
Diploma£1.52B5.92£115.40M£137.3048.98

Howden Joinery Group has a net margin of 11.07% compared to Diploma's net margin of 8.99%. Howden Joinery Group's return on equity of 23.58% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
Howden Joinery Group11.07% 23.58% 10.70%
Diploma 8.99%14.17%8.32%

Howden Joinery Group pays an annual dividend of GBX 21.30 per share and has a dividend yield of 2.9%. Diploma pays an annual dividend of GBX 60.20 per share and has a dividend yield of 0.9%. Howden Joinery Group pays out 43.5% of its earnings in the form of a dividend. Diploma pays out 43.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Howden Joinery Group has a beta of 1.298, meaning that its share price is 30% more volatile than the broader market. Comparatively, Diploma has a beta of 0.917, meaning that its share price is 8% less volatile than the broader market.

Howden Joinery Group presently has a consensus target price of GBX 924, indicating a potential upside of 25.54%. Diploma has a consensus target price of GBX 6,251.25, indicating a potential downside of 7.04%. Given Howden Joinery Group's higher possible upside, research analysts plainly believe Howden Joinery Group is more favorable than Diploma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howden Joinery Group
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63

Summary

Howden Joinery Group beats Diploma on 9 of the 17 factors compared between the two stocks.

How does Diploma compare to City of London?

Diploma (LON:DPLM) and City of London (LON:CTY) are both mid-cap personal services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Diploma has a beta of 0.917, indicating that its stock price is 8% less volatile than the broader market. Comparatively, City of London has a beta of 0.8609003, indicating that its stock price is 14% less volatile than the broader market.

In the previous week, City of London had 3 more articles in the media than Diploma. MarketBeat recorded 4 mentions for City of London and 1 mentions for Diploma. City of London's average media sentiment score of 0.89 beat Diploma's score of 0.00 indicating that City of London is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Diploma
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
City of London
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Diploma presently has a consensus price target of GBX 6,251.25, suggesting a potential downside of 7.04%. Given Diploma's stronger consensus rating and higher probable upside, research analysts plainly believe Diploma is more favorable than City of London.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
City of London
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

68.2% of Diploma shares are held by institutional investors. Comparatively, 8.7% of City of London shares are held by institutional investors. 1.1% of Diploma shares are held by insiders. Comparatively, 0.1% of City of London shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Diploma pays an annual dividend of GBX 60.20 per share and has a dividend yield of 0.9%. City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.9%. Diploma pays out 43.8% of its earnings in the form of a dividend. City of London pays out 18.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. City of London is clearly the better dividend stock, given its higher yield and lower payout ratio.

City of London has a net margin of 97.40% compared to Diploma's net margin of 8.99%. City of London's return on equity of 22.92% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma8.99% 14.17% 8.32%
City of London 97.40%22.92%4.00%

City of London has lower revenue, but higher earnings than Diploma. City of London is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.52B5.92£115.40M£137.3048.98
City of London£568.96M4.92£294.08M£113.994.81

Summary

Diploma beats City of London on 11 of the 18 factors compared between the two stocks.

How does Diploma compare to Genus?

Diploma (LON:DPLM) and Genus (LON:GNS) are both personal services companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Diploma has a beta of 0.917, indicating that its share price is 8% less volatile than the broader market. Comparatively, Genus has a beta of 0.895, indicating that its share price is 11% less volatile than the broader market.

Diploma has higher revenue and earnings than Genus. Genus is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.52B5.92£115.40M£137.3048.98
Genus£672M2.29£7.87M£71.0032.59

Diploma currently has a consensus target price of GBX 6,251.25, suggesting a potential downside of 7.04%. Genus has a consensus target price of GBX 3,216.67, suggesting a potential upside of 39.01%. Given Genus' stronger consensus rating and higher probable upside, analysts plainly believe Genus is more favorable than Diploma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Diploma has a net margin of 8.99% compared to Genus' net margin of 7.07%. Diploma's return on equity of 14.17% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma8.99% 14.17% 8.32%
Genus 7.07%9.70%3.31%

In the previous week, Genus had 5 more articles in the media than Diploma. MarketBeat recorded 6 mentions for Genus and 1 mentions for Diploma. Genus' average media sentiment score of 0.21 beat Diploma's score of 0.00 indicating that Genus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Diploma
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Genus
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

68.2% of Diploma shares are held by institutional investors. Comparatively, 53.1% of Genus shares are held by institutional investors. 1.1% of Diploma shares are held by insiders. Comparatively, 0.7% of Genus shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Diploma pays an annual dividend of GBX 60.20 per share and has a dividend yield of 0.9%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.4%. Diploma pays out 43.8% of its earnings in the form of a dividend. Genus pays out 45.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Diploma beats Genus on 13 of the 18 factors compared between the two stocks.

Get Diploma News Delivered to You Automatically

Sign up to receive the latest news and ratings for DPLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DPLM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DPLM vs. The Competition

MetricDiplomaIndustrial Distribution IndustryIndustrials SectorLON Exchange
Market Cap£9.02B£5.71B£9.32B£2.78B
Dividend Yield0.93%4.37%3.57%6.09%
P/E Ratio48.9823.6224.83365.92
Price / Sales5.9253.895,392.9288,371.87
Price / Cash87.8255.6527.9227.89
Price / Book10.092.614.787.70
Net Income£115.40M£242.73M£792.39M£5.89B
7 Day Performance-4.41%-2.34%0.17%0.48%
1 Month Performance-0.52%1.31%3.64%2.53%
1 Year Performance60.73%23.43%38.18%87.11%

Diploma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DPLM
Diploma
0.9478 of 5 stars
GBX 6,725
+0.6%
GBX 6,251.25
-7.0%
+57.2%£9.02B£1.52B48.983,500
IGG
IG Group
N/AGBX 1,530
-0.2%
GBX 1,302
-14.9%
+40.0%£5.07B£949.10M14.562,754
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50MN/A2,457
HWDN
Howden Joinery Group
N/AGBX 777.50
+1.6%
GBX 924
+18.8%
-12.4%£4.19B£2.42B15.8712,000
CTY
City of London
N/AGBX 551.70
+0.9%
N/A+15.6%£2.80B£568.96M4.84N/A

Related Companies and Tools


This page (LON:DPLM) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners